Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07420400 · ClinicalTrials.gov registry record

Non-Invasive Detection of Right-to-Left Cardiac Shunts

A clinical trial of Patent Foramen Ovale (PFO), sponsored by Scripps Health.

Recruiting
Registry status
75
Enrollment target
1
Study location

NCT07420400 is a study of Patent Foramen Ovale (PFO) that is actively recruiting participants, run by Scripps Health. The registered enrollment target is 75 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07420400, a study of Patent Foramen Ovale (PFO), is actively recruiting participants, sponsored by Scripps Health.

RECRUITING
Registry status
75 participants
Enrollment target
1
Study location

Study Summary

This study will test the sensitivity of a novel, battery-powered, non-invasive ultrasound device to detect a right-to-left shunt

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Point-of-care ultrasound

Study Locations (1)

California

  • Scripps Memorial Hospital La Jolla - La Jolla

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2026-01-07
Est. Completion 2027-03-01

Sponsor

Scripps Health

30 total trials

What the Registry Record Tells You About NCT07420400

The ClinicalTrials.gov registry entry for NCT07420400 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Health, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Patent Foramen Ovale (PFO) appearing as the primary indexed condition, and to 1 intervention - of which Point-of-care ultrasound is the first listed.

NCT07420400 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07420400 about?

NCT07420400 is a clinical study titled "Non-Invasive Detection of Right-to-Left Cardiac Shunts". This study will test the sensitivity of a novel, battery-powered, non-invasive ultrasound device to detect a right-to-left shunt

What is the current status of trial NCT07420400?

This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2026-01-07. Estimated completion is 2027-03-01.

What conditions does trial NCT07420400 study?

This clinical trial studies the following conditions: Patent Foramen Ovale (PFO).

What interventions are being tested in trial NCT07420400?

The interventions under investigation include: Point-of-care ultrasound (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07420400?

This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07420400 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.